tirzepatide update trial shows additional 21.1% weight loss following intensive lifestyle intervention FDA Says Shortage of GLP-1

Semaglutide aids weight loss by reducing appetite and slowing digestion

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Science explains it

Understanding individual metabolic factors and genetic predispositions can help optimize outcomes with medical guidance

Tirzepatide affects levothyroxine absorption through delayed gastric emptying

I felt drained and annoyed at myself by evening every single day